On March 3, the U.S. Food and Drug Administration (FDA) approved octiva (desmopressin acetate) nasal spray for adults with nocturnal polyuria. Read more
FDA approves nasal spray for nocturnal polyuria
The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.